SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Hewlett S, Nicklin J, Treharne GJ. Fatigue in musculoskeletal conditions. Topical Reviews Series 6: No 1. Arthritis Research UK; 2008. URL: http://www.arthritisresearchuk.org/files/6641_25022010173830.pdf.
  • 2
    Hewlett S, Cockshott Z, Byron M, Kitchen K, Tipler S, Pope D, et al. Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Rheum 2005; 53: 697702.
  • 3
    Repping-Wuts H, Uitterhoeve R, van Riel P, van Achterberg T. Fatigue as experienced by patients with rheumatoid arthritis (RA): a qualitative study. Int J Nurs Stud 2008; 45: 9951002.
  • 4
    Power JD, Badley EM, French MR, Wall AJ, Hawker GA. Fatigue in osteoarthritis: a qualitative study. BMC Musculoskelet Disord 2008; 9: 63.
  • 5
    Kirwan JR, Minnock P, Adebajo A, Bresnihan B, Choy E, de Wit M, et al. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol 2007; 34: 1747.
  • 6
    Choy EH, Arnold LM, Clauw DJ, Crofford LJ, Glass JM, Simon LS, et al. Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. J Rheumatol 2009; 36: 23304.
  • 7
    Hewlett S, Hehir M, Kirwan JR. Measuring fatigue in rheumatoid arthritis: a systematic review of scales in use. Arthritis Rheum 2007; 57: 42939.
  • 8
    Zonna-Nacach A, Roseman JM, McGwin G Jr, Friedman AW, Baethge BA, Reveille JD, et al. Systemic lupus erythematosus in three ethnic groups. VI. Factors associated with fatigue within 5 years of criteria diagnosis. Lupus 2000; 9: 1019.
  • 9
    Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford) 2006; 45: 8859.
  • 10
    Hewlett S, Chalder T, Choy E, Cramp F, Davis B, Dures E, et al. Fatigue in rheumatoid arthritis: time for a conceptual model [editorial]. Rheumatology (Oxford) 2011; 50: 10046.
  • 11
    Cohen J. Statistical power analysis for the behavioural sciences. 2nd ed. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. p. 7981.
  • 12
    Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcomes measures for use in clinical trials. Health Technol Assess 1998; 2: 174.
  • 13
    Nicklin J, Cramp F, Kirwan J, Urban M, Hewlett S. Collaboration with patients in the design of patient-reported outcome measures: capturing the experience of fatigue in rheumatoid arthritis. Arthritis Care Res 2010; 62: 15528.
  • 14
    Nicklin J, Cramp F, Kirwan J, Greenwood R, Urban M, Hewlett S. Measuring fatigue in RA: a cross-sectional study to evaluate the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire, Visual Analog Scales, and Numerical Rating Scales. Arthritis Care Res 2010; 62: 155968.
  • 15
    Nicklin J. The development of scales to measure fatigue in people with rheumatoid arthritis. Bristol (UK): University of the West of England; 2009.
  • 16
    Dures E, Hewlett S, Kirwan J, Cramp F, Nicklin J, Greenwood R. Test-retest reliability of the Bristol Rheumatoid Arthritis Fatigue Scales (BRAFs) [abstract]. Rheumatology (Oxford) 2011; 50: Suppl 3: 109.
  • 17
    Hewlett S, Dures E, Kirwan JR, Cramp F, Nicklin J, Almeida C, et al. Sensitivity to change of the Bristol Rheumatoid Arthritis Fatigue Scales [abstract]. Arthritis Rheum 2011; 63 Suppl.
  • 18
    Downie WW, Leatham PA, Rhind VM, Wright V, Branco JA, Anderson JA. Studies with pain rating scales. Ann Rheum Dis 1978; 37: 37881.
  • 19
    Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res 1993; 37: 14753.
  • 20
    Cella M, Chalder T. Measuring fatigue in clinical and community settings. J Psychosom Res 2010; 69: 1722.
  • 21
    Naschitz JE, Rozenbaum M, Fields MC, Enis S, Manor H, Dreyfuss D, et al. Cardiovascular reactivity in fibromyalgia: evidence for pathogenic heterogeneity. J Rheumatol 2005; 32: 3359.
  • 22
    Tench CM, McCurdie I, White PD, D'Cruz PD. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford) 2000; 39: 124954.
  • 23
    Strombeck B, Ekdahl C, Manthorpe R, Jacobsson LT. Physical capacity in women with primary Sjogren's syndrome: a controlled study. Arthritis Rheum 2003; 49: 6818.
  • 24
    Tench C, Bentley D, Vleck V, McCurdie I, White P, D'Cruz D. Aerobic fitness, fatigue, and physical disability in systemic lupus erythematosus. J Rheumatol 2002; 29: 47481.
  • 25
    White PD, Henderson M, Pearson RM, Coldrick AR, White AG, Kidd BL. Illness behaviour and psychosocial factors in diffuse upper limb pain disorder: a case-control study. J Rheumatol 2003; 30: 13945.
  • 26
    Tench CM, McCarthy JM, McCurdie I, White PD, D'Cruz PD. Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology (Oxford) 2003; 42: 10504.
  • 27
    Henderson M, Kidd BL, Pearson RM, White PD. Chronic upper limb pain: an exploration of the biopsychosocial model. J Rheumatol 2005; 32: 11822.
  • 28
    Lwin CT, Bishay M, Platts RG, Booth DA, Bowman SJ. The assessment of fatigue in primary Sjogren's syndrome. Scand J Rheumatol 2003; 32: 337.
  • 29
    Vercoulen J, Swanink C, Fennis J, Galama J, van der Meer J, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994; 38: 38392.
  • 30
    Raterman HG, Hoving JL, Nurmohamed MT, Herenius MM, Sluiter JK, Lems WF, et al. Work ability: a new outcome measure in rheumatoid arthritis? Scand J Rheumatol 2010; 39: 12731.
  • 31
    Van Hoogmoed D, Fransen J, Bleijenberg G, van Riel P. Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxford) 2010; 49: 1294302.
  • 32
    De Croon EM, Sluiter JK, Nijssen TF, Kammeijer M, Dijkmans BA, Lankhorst GJ, et al. Work ability of Dutch employees with rheumatoid arthritis. Scand J Rheumatol 2005; 43: 27783.
  • 33
    Hoving JL, Bartelds GM, Sluiter JK, Sadiraj K, Groot I, Lems WF, et al. Perceived work ability, quality of life and fatigue in patients with rheumatoid arthritis after a 6 month course of TNF inhibitors: prospective intervention study and partial economic evaluation. Scand J Rheumatol 2009; 38: 24650.
  • 34
    Evers AW, Kraaimaat FW, van Riel PL, de Jong AJ. Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: an RCT. Pain 2002; 100: 14153.
  • 35
    Zijlstra TR, Taal E, van de Laar MA, Rasker JJ. Validation of a Dutch translation of the fibromyalgia impact questionnaire. Rheumatology (Oxford) 2007; 46: 1314.
  • 36
    Van Koulil S, Kraaimaat FW, van Lankveld W, van Riel PL, Evers AW. A patient's persepctive on multidisciplinary treatment gain for fibromyalgia: an indicator for pre-post treatment effects? Arthritis Rheum 2009; 61: 162632.
  • 37
    Van Hoogmoed D, Fransen J, Bleijenberg G, van Riel PL. How to assess fatigue in rheumatoid arthritis: validity and reliability of the Checklist Individual Strength [abstract]. Arthritis Rheum 2008; 58 Suppl: S868.
  • 38
    Knoop H, Van der Meer JW, Bleijenberg G. Guided self-instructions for people with chronic fatigue syndrome: randomized controlled trial. Br J Psychiatry 2008; 193: 3401.
  • 39
    Beurskens A, Bultmann U, Kant I, Vercoulen J, Bleijenberg G, Swaen G. Fatigue among working people: validity of a questionnaire measure. Occup Environ Med 2000; 57: 3537.
  • 40
    Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The Fatigue Severity Scale: application to patients with multiple sclerosis and systemic lupus erythematosis. Arch Neurol 1989; 46: 11213.
  • 41
    Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria for Fatigue. Measurement of fatigue in systemic lupus erythematosus: a systematic review. Arthritis Rheum 2007; 57: 134857.
  • 42
    Schentag CT, Beaton M, Rahman P, Husted J, Gladman DD. Prevalence and correlates of fatigue in psoriatic arthritis (PsA) [abstract]. Arthritis Rheum 2000; 43 Suppl: S105.
  • 43
    Mancuso CA, Rincon M, Sayles W, Paget SA. Psychosocial variables and fatigue: a longitudinal study comparing individuals with rheumatoid arthritis and healthy controls. J Rheumatol 2006; 33: 1496502.
  • 44
    Harboe E, Greve OJ, Beyer M, Goransson LG, Tjensvoll AB, Maroni S, et al. Fatigue is associated with cerebral white matter hyperintensities in patients with systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 2008; 79: 199201.
  • 45
    Schentag CT, Cichon J, MacKinnon A, Gladman DD, Urowitz MB. Validation and normative data for the 0–10 point scale version of the fatigue severity scale (FSS) [abstract]. Arthritis Rheum 2000; 43 Suppl: S177.
  • 46
    Mattsson M, Moller B, Lundberg IE, Gard G, Bostrom C. Reliability and validity of the Fatigue Severity Scale in Swedish for patients with systemic lupus erythematosus. Scand J Rheumatol 2008; 37: 26977.
  • 47
    Austin JS, Maisiak RS, Macrina DM, Heck LW. Health outcome improvements in patients with systemic lupus erythematosus using two telephone counseling interventions. Arthritis Care Res 1996; 9: 3919.
  • 48
    Omdal R, Mellgren SI, Koldingsnes W, Jacobsen EA, Husby G. Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, anti-phospholipid antibodies or other disease characteristics. J Rheumatol 2002; 29: 4826.
  • 49
    Chandran V, Behella S, Schentag C, Gladman DD. Functional Assessment of Chronic Illness Therapy-Fatigue Scale is valid in patients with psoriatic arthritis. Ann Rheum Dis 2007; 66: 9369.
  • 50
    Wanders AJ, Gorman JD, Davis JC, Landewe RB, van der Heijde DM. Responsiveness and discriminative capacity of the assessments in ankylosing spondylitis disease-controlling antirheumatic therapy core set and other outcome measures in a trial of etanercept in ankylosing spondylitis. Arthritis Rheum 2004; 51: 18.
  • 51
    Ramsey-Goldman R, Schilling EM, Dunlop D, Langman C, Greenland P, Thomas RJ, et al. A pilot study on the effects of exercise in patients with systemic lupus erythematosus. Arthritis Care Res 2000; 13: 2629.
  • 52
    Pouchot J, Kherani RB, Brant R, Lacaille D, Lehman AJ, Ensworth S, et al. Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis. J Clin Epidemiol 2008; 61: 70513.
  • 53
    Goligher EC, Pouchot J, Brant R, Kherani R, Avina-Zubieta JA, Lacaille D, et al. Minimal clinically important difference for seven fatigue measures in patients with systemic lupus erythematosus. J Rheumatol 2008; 35: 63542.
  • 54
    Cross M, Lapsley H, Barcenilla A, Brooks P, March L. Association between measures of fatigue and health-related quality of life in rheumatoid arthritis and osteoarthritis. The Patient: Patient-Centered Outcomes Research 2008; 1: 97104.
  • 55
    Schwartz JE, Jandorf L, Krupp LB. The measurement of fatigue: a new instrument. J Psychosom Res 1993; 37: 75362.
  • 56
    Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) Measurement System. J Pain Symptom Manage 1997; 13: 6374.
  • 57
    Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 2005; 32: 8119.
  • 58
    Walker J, Gordon T, Lester S, Downie-Doyle S, McEvoy D, Pile K, et al. Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjogren's syndrome. J Rheumatol 2003; 30: 240612.
  • 59
    Gladman DD, Mease PJ, Cifaldi MA, Perdok RJ, Sasso E, Medich J. Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab effectiveness in psoriatic arthritis trial. Ann Rheum Dis 2007; 66: 1638.
  • 60
    Mittendorf T, Dietz B, Sterz R, Kupper H, Cifaldi MA, von der Schulenburg JM. Improvement and long-term maintenance of quality of life during treatment with adalimumab in severe rheumatoid arthritis. J Rheumatol 2007; 34: 234350.
  • 61
    Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, et al. Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 2006; 54: 2793806.
  • 62
    Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, et al. Adalimumab, a fully human anti–tumor necrosis factor α monocolonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate. Arthritis Rheum 2003; 48: 3545.
  • 63
    Segal B, Bowman SJ, Fox PC, Vivino FB, Murukutla N, Brodscholl J, et al. Primary Sjogren's syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes 2009; 7: 46.
  • 64
    Cella D, Lai JS, Chang CH, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 2002; 94: 52838.
  • 65
    Nikolaus S, Bode C, Taal E, van de Laar MA. Four different patterns of fatigue in rheumatoid arthritis patients: results of a Q-sort study. Rheumatology (Oxford) 2010; 49: 21919.
  • 66
    Tack B. Dimensions and correlates of fatigue in older adults with rheumatoid arthritis. San Francisco: University of California; 1991.
  • 67
    Piper B, Lindsey A, Dodd M, Ferketich S, Paul S, Weller S. The development of an instrument to measure the subjective dimension of fatigue. In: Funk S, Tornquist E, Champagne M, Wiese R, editors. Key aspects of comfort: management of pain, fatigue, and nausea. New York: Springer; 1989. p. 199207.
  • 68
    Belza BL. Comparison of self-reported fatigue in rheumatoid arthritis and controls. J Rheumatol 1995; 22: 63943.
  • 69
    Belza B, Henke C, Yelin E, Epstein W, Gilliss C. Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res 1993; 42: 939.
  • 70
    Wolfe F. Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7,760 patients. J Rheumatol 2004; 31: 1896902.
  • 71
    Stebbings S, Herbison P, Doyle TC, Treharne G, Highton J. A comparison of fatigue correlates in rheumatoid arthritis and osteoarthritis: disparity in associations with disability, anxiety and sleep disturbance. Rheumatology (Oxford) 2010; 49: 3617.
  • 72
    Turan Y, Duruoz MT, Bal S, Guvenc A, Cerrahoglu L, Gurgan A. Assessment of fatigue in patients with ankylosing spondylitis. Rheumatol Int 2007; 27: 84752.
  • 73
    Neuberger GB, Press AN, Lindsley HB, Hinton R, Cagle PE, Carlson K, et al. Effects of exercise on fatigue, aerobic fitness, and disease activity measures in persons with rheumatoid arthritis. Res Nurs Health 1997; 20: 195204.
  • 74
    Arnold LM, Zlateva G, Sadosky A, Emir B, Whalen E. Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of Pregabalin. Pain Med 2011; 12: 2607.
  • 75
    Arnold LM, Chatamra K, Hirsch I, Stoker M. Safety and efficacy of Esreboxetine in patients with fibromyalgia: an 8-week, multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 2010; 32: 161832.
  • 76
    Yacoub YI, Amine B, Laatiris A, Abouqal R, Hajjaj-Hassouni N. Assessment of fatigue in Moroccan patients with ankylosing spondylitis. Clin Rheumatol 2010; 29: 12959.
  • 77
    Jump RL, Fifield J, Tennen H, Reisine S, Giuliano AJ. History of affective disorder and the experience of fatigue in rheumatoid arthritis. Arthritis Rheum 2004; 51: 23945.
  • 78
    Bouzubar FF. Self-reported fatigue in individuals with knee osteoarthritis. Pittsburgh: University of Pittsburgh; 2003.
  • 79
    Meek PM, Nail LM, Barsevick A, Schwartz AL, Stephen S, Whitmer K, et al. Psychometric testing of fatigue instruments for use with cancer patients. Nurs Res 2000; 49: 18190.
  • 80
    Smets E, Garssen B, Bonke B, De Haes J. The Multidimensional Fatigue Inventory (MFI): psychometric qualities of an instrument to assess fatigue. J Psychosomatic Res 1995; 39: 31525.
  • 81
    Smets E, Garssen B, Cull A, de Haes J. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer 1996; 73: 2415.
  • 82
    Barendregt P, Visser M, Smets E, Tulen J, van den Meiracker A, Boomsma F, et al. Fatigue in primary Sjogren's syndrome. Ann Rheum Dis 1998; 57: 2915.
  • 83
    Van Tubergen A, Coenen J, Landewe R, Spoorenberg A, Chorus A, Boonen A, et al. Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis. Arthritis Rheum 2002; 47: 816.
  • 84
    Forsblad d'Elia H, Rehnberg E, Kvist G, Ericsson A, Konttinen YT, Mannerkorpi K. Fatigue and blood pressure in primary Sjogren's syndrome. Scand J Rheumatol 2008; 37: 28492.
  • 85
    Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos GA. Impact of fatigue on health-related quality of life in rheumatoid arthritis. Arthritis Rheum 2004; 51: 57885.
  • 86
    Goodchild CE, Treharne GJ, Booth DA, Kitas GD, Bowman SJ. Measuring fatigue among women with Sjogren's syndrome or rheumatoid arthritis: a comparison of the Profile of Fatigue (ProF) and the Multidimensional Fatigue Inventory (MFI). Musculoskelet Care 2008; 6: 3148.
  • 87
    Ericsson A, Mannerkorpi K. Assessment of fatigue in patients with fibromyalgia and chronic widespread pain: reliability and validity of the Swedish version of the MFI-20. Disabil Rehabil 2007; 29: 166570.
  • 88
    Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y. Milnacipran for the treatment of fibromyalgia in adults: a 15 week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 2008; 30: 19882004.
  • 89
    Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core scales, multidimensional fatigue scale, and cancer module. Cancer 2002; 94: 2090106.
  • 90
    Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the Pediatric Quality of Life Inventory. Med Care 1999; 37: 12639.
  • 91
    Varni JW, Burwinkle TM, Szer IS. The PedsQL Multidimensional Fatigue Scale in pediatric rheumatology: reliability and validity. J Rheumatol 2004; 31: 2494500.
  • 92
    Varni JW, Burwinkle TM, Limbers CA, Szer IS. The PedsQL as a patient-reported outcome in children and adolescents with fibromyalgia: an analysis of OMERACT domains. Health Qual Life Outcomes 2007; 5: 9.
  • 93
    Ringold S, Wallace CA, Rivara FP. Health-related quality of life, physical function, fatigue and disease activity in children with established polyarticular juvenile idiopathic arthritis. J Rheumatol 2009; 36: 13306.
  • 94
    Varni JW, Limbers CA. The PedsQL Multidimensional Fatigue Scale in young adults: feasibility, reliability and validity in a University student population. Qual Life Res 2008; 17: 10514.
  • 95
    Chiang YC, Hinds PS, Yeh CH, Yang CP. Development and psychometric testing of a Chinese version of the Fatigue Scale-Children in Taiwan. J Clin Nursing 2008; 17: 120110.
  • 96
    Bowman SJ, Booth DA, Platts RG, and the UK Sjogren's Interest Group. Measurement of fatigue and discomfort in primary Sjorgren's syndrome using a new questionnaire tool. Rheumatology (Oxford) 2004; 43: 75864.
  • 97
    Bowman SJ, Hamburger J, Richards A, Barry RJ, Sauz S. Patient-reported outcomes in primary Sjogren's syndrome: comparison of the long and short versions of the Profile of Fatigue and Discomfort-Sicca Symptoms Inventory. Rheumatology (Oxford) 2009; 48: 1403.
  • 98
    Strombeck B, Theander E, Jacobsson LT. Assessment of fatigue in primary Sjogren's syndrome: the Swedish version of the Profile of Fatigue. Scand J Rheumatol 2005; 34: 4559.
  • 99
    Barry RJ, Sutcliffe N, Isenberg DA, Price E, Goldblatt F, Adler M, et al. The Sjogren's Syndrome Damage Index: a damage index for use in clinical trials and observational studies in primary Sjogren's syndrome. Rheumatology (Oxford) 2008; 47: 11938.
  • 100
    Dass S, Bowman SJ, Vital EM, Ikeda K, Pease CT, Hamburger J, et al. Reduction of fatigue in Sjogren's syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Ann Rheum Dis 2008; 67: 15414.
  • 101
    Goodchild EC, Treharne GJ, Booth DA, Bowman SJ. Daytime patterning of fatigue and its associations with the previous night's discomfort and poor sleep among women with primary Sjogren's syndrome or rheumatoid arthritis. Musculoskelet Care 2010; 8: 10717.
  • 102
    Segal B, Thomas W, Rogers T, Leon JM, Hughes P, Patel D, et al. Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren's syndrome. Arthritis Rheum 2008; 59: 17807.
  • 103
    Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): conceptual framework and item selection. Med Care 1992; 30: 47383.
  • 104
    Keystone E, Burmester GR, Furie R, Loveless JE, Emery P, Kremer J, et al. Improvement in patient-reported outcomes in a Rituximab trial in patients with severe rheumatoid arthritis refractory to anti–tumor necrosis factor therapy. Arthritis Rheum 2008; 59: 78593.
  • 105
    Gilboe IM, Kvien TK, Husby G. Disease course in systemic lupus erythematosus: changes in health status, disease activity and organ damage after 2 years. J Rheumatol 2001; 28: 26674.
  • 106
    Wolfe F, Michaud K, Li T, Katz RS. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, non-inflammatory rheumatic disorders and fibromyalgia. J Rheumatol 2010; 37: 296304.
  • 107
    Soderman P, Malchau H. Validity and reliability of the Swedish WOMAC osteoarthritis index: a self-administered disease-specific questionnaire (WOMAC) versus generic instruments (SF-36 and NHP). Acta Orthop Scand 2000; 71: 3946.
  • 108
    Tuttleman M, Pillemer SR, Tilley BC, Fowler SE, Budkley LM, Alarcon GM, et al. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. J Rheumatol 1997; 24: 19105.
  • 109
    Dagfinrud H, Vollestad NK, Loge JH, Kvien TK, Mengshoel AM. Fatigue in patients with ankylosing spondylitis: a comparison with the general population and associations with clinical and self-reported measures. Arthritis Rheum 2005; 53: 511.
  • 110
    Busija L, Osborne RH, Nilsdotter A, Buchbinder R, Roos EM. Magnitude and meaningfulness of change in SF-36 scores in four types of orthopaedic surgery. Health Qual Life Outcomes 2008; 6: 55.
  • 111
    Davey RC, Matthes Edwards S, Cochrane T. Test-retest reliability of lower extremity functional and self-reported measures in elderly with osteoarthritis. Adv Physiother 2003; 5: 15560.
  • 112
    Birrell FN, Hassell AB, Jones PW, Dawes PT. How does the Short Form 36 Health Questionnaire (SF-36) in rheumatoid arthritis (RA) relate to RA outcome measures and SF-36 population values? A cross-sectional study. Clin Rheumatol 2000; 19: 1959.
  • 113
    Loge JH, Kaasa S, Hjermstad MJ, Kvien TK. Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability and construct validity. J Clin Epidemiol 1998; 51: 106976.
  • 114
    Linde L, Sorensen J, Ostergaard M, Horslev-Peterson, Hetland ML. Health-related quality of life: validity, reliability and responsiveness of SF-36, EQ-15D, EQ-5D, RAQoL and HAQ in patients with rheumatoid arthritis. J Rheumatol 2008; 35: 152837.
  • 115
    Koh ET, Leong KP, Tsou IY, Lim VH, Pong LY, Chong SY, et al. The reliability, validity and sensitivity to change of the Chinese version of SF-36 in oriental patients with rheumatoid arthritis. Rheumatology (Oxford) 2006; 45: 10238.
  • 116
    Saad AA, Ashcroft DM, Watson KD, Symmons DP, Noyce PR, Hyrich KL. Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti–tumor necrosis factor therapies. Arthritis Care Res 2010; 62: 34553.
  • 117
    Wells G, Li T, Maxwell L, MacLean R, Tugwell P. Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis. Ann Rheum Dis 2008; 67: 2605.
  • 118
    Riemsma RP, Rasker JJ, Taal E, Griep EN, Wouters JM, Wiegman O. Fatigue in rheumatoid arthritis: the role of self-efficacy and problematic social support. Br J Rheumatol 1998; 37: 10426.
  • 119
    Mengshoel AM, Forre O. Pain and fatigue in patients with rheumatic disorders. Clin Rheumatol 1993; 12: 51522.
  • 120
    Dernis-Labous E, Messow M, Dougados M. Assessment of fatigue in the management of patients with ankylosing spondylitis. Rheumatology (Oxford) 2003; 42: 15238.
  • 121
    Rohekar G, Pope J. Test-retest reliability of patient global assessment and physician global assessment in rheumatoid arthritis. J Rheumatol 2009; 36: 217882.
  • 122
    Khanna D, Pope J, Khanna PP, Maloney M, Samedi N, Norrie D, et al. The minimally important difference for the fatigue visual analog scale in patients with rheumatoid arthritis followed in an academic clinical practice. J Rheumatol 2008; 35: 233943.
  • 123
    Wells G, Li T, Maxwell L, MacLean R, Tugwell P. Determining the minimal clinically important differences in activity, fatigue, and sleep quality in patients with rheumatoid arthritis. J Rheumatol 2007; 34: 2809.
  • 124
    Slatkowsky-Christensen B, Mowinckel P, Loge JH, Kvien TK. Health-related quality of life in women with symptomatic hand osteoarthritis: a comparison with rheumatoid arthritis patients, healthy controls, and normative data. Arthritis Rheum 2007; 57: 14049.
  • 125
    Wolfe F, Hawley D, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 1996; 23: 140717.
  • 126
    Wolfe F. Determinants of WOMAC function, pain and stiffness scores: evidence for the role of low back pain, symptoms counts, fatigue and depression in osteoarthritis, rheumatoid arthritis and fibromyalgia. Rheumatology (Oxford) 1999; 38: 35561.
  • 127
    Colangelo KJ, Pope JE, Peschken C. The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36. J Rheumatol 2009; 36: 22317.
  • 128
    Kwok T, Pope JE. Minimally important difference for patient-reported outcomes in psoriatic arthritis: health assessment questionnaire and pain, fatigue, and global visual analog scales. J Rheumatol 2010; 37: 10248.
  • 129
    Braun J, van der Heijde D, Doyle MK, Han C, Deodhar A, Inman R, et al. Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with Infliximab. Arthritis Rheum 2009; 61: 10326.
  • 130
    Ide MR, Laurindo IM, Rodrigues-Junior AL, Tanaka C. Effect of aquatic respiratory exercise-based program in patients with fibromyalgia. Int J Rheum Dis 2008; 11: 13140.
  • 131
    Heiberg MS, Kaufmann C, Rodevand E, Mikkelsen K, Koldingsnes W, Mowinckel P, et al. The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study. Ann Rheum Dis 2007; 66: 103842.
  • 132
    Heiberg T, Finset A, Uhlig T, Kvien TK. Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Ann Rheum Dis 2005; 64: 1915.
  • 133
    Bellamy N. Musculoskeletal clinical metrology. London: Kluwer Academic Publishers; 1993.
  • 134
    Brazier J, Deverill M, Green C, Harper R, Booth A. A review of the use of health status measures in economic evaluation. Health Technol Assess 1999; 3: 9.
  • 135
    Streiner DL, Norman GR. Health measurement scales: A practical guide to their development and use. 4th ed. Oxford: Oxford University Press; 2008.
  • 136
    Huskisson EC. Visual analogue scales. In: Melzack R, editor. Pain measurement and assessment. New York: Raven Press; 1983.